$4.36
-0.10 (-2.24%)
Open$4.60
Previous Close$4.46
Day High$4.61
Day Low$4.27
52W High$9.20
52W Low$3.53
Volume—
Avg Volume54.5K
Market Cap46.71M
P/E Ratio—
EPS$-2.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+86.2% upside
Current
$4.36
$4.36
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 34.57M | 21.69M | 9.68M |
| Net Income | -14,446,595 | -8,158,845 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -26,973,332 | -16,079,734 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |